Rentschler Biopharma

Rentschler Biopharma, established in 1927, stands as a distinguished leader in the biopharmaceutical manufacturing sector. The company provides comprehensive contract development and manufacturing services for diverse therapeutic modalities. Their technical expertise is centered on the production of complex and difficult-to-manufacture proteins, such as multispecific antibodies. By offering integrated, end-to-end service solutions, Rentschler Biopharma effectively supports the entire biopharmaceutical value chain, from initial project planning and bioprocess development to navigating complex regulatory landscapes.

Currently operating with a dedicated workforce of 1,000-5,000 employees, the organization maintains a strategic operational footprint across 4 global locations. Their state-of-the-art facilities, situated in Germany and the United States, are specifically engineered to handle sophisticated bioprocess requirements. This infrastructure ensures rigorous quality control and high-capacity production standards for a global client base. The company consistently leverages its deep-rooted experience in innovation, project management, and technical consulting to address the highly specialized and evolving needs of the modern pharmaceutical and biotechnology sectors.

Rentschler Biopharma continues to solidify its market position within the European and North American regions, maintaining an unwavering commitment to technical excellence and operational reliability. Meet Rentschler Biopharma's team to learn about their leadership, organizational structure, and the experts driving their innovation. With nearly a century of industry expertise, the firm remains a critical strategic partner for organizations seeking reliable, high-scale biopharmaceutical manufacturing capabilities and advanced therapeutic development support.